Most often in the study of cancer, fibronectin is examined as a marker of the mesenchymal phenotype associated with EMT for the purpose of metastasis36, or is considered primarily in the context of fibroblastic stroma in the tumor microenvironment. Here, FN1 is linked to neoplasm.